Android app Apple app link

NewAmsterdam Pharma Company N.V. (NAMS) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$31.44

$0.44 (-1.38%)
Last update: 04:45 AM EST
Day's range
$31.26
Day's range
$32.28

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
01/06/2026 Leerink Partners Roanna Ruiz $55.00 $33.48   64.28%
10/20/2025 H.C. Wainwright Joseph Pantginis $52.00 $36.40   42.86%
12/30/2024 H.C. Wainwright Ed Arce $48.00 $25.60   87.5%
11/20/2024 Leerink Partners Roanna Ruiz $45.00 $20.01   124.89%
09/23/2024 Piper Sandler Yasmeen Rahimi $37.00 $15.95   131.97%
08/28/2024 Needham Serge Belanger $36.00 $16.77   114.67%

NewAmsterdam Pharma Company N.V. FAQ's

NewAmsterdam Pharma Company N.V. has been rated by research analysts at RBC Capital, Leerink Partners, Goldman Sachs, H.C. Wainwright, Wells Fargo, UBS in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.